Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

New-look TAVR valve shows early promise in patients with severe AS
One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.
TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock
TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options.
Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology
The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.
SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology
Interventional cardiologists from all over the world will gather for three days of educational sessions, late-breaking presentations, live cases and more. The festivities begin Thursday, May 2, in Long Beach, California.
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.

SCAI 2022 interventional cardiology TAVR CTO PCI TPV cath labs

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

May 20, 2022

New guidelines detail PFO management, including when to consider closure

The new guidance document was designed to provide helpful information on a topic "surrounded by controversy."

May 20, 2022

Kirk Garratt, past SCAI president, explains the impact of the iodine contrast shortage on interventional cardiology and the cath lab. #SCAI

VIDEO: How the iodine contrast shortage is impacting interventional cath labs

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

May 19, 2022

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022

Intravascular lithotripsy tied to superior long-term PAD, PCI outcomes at SCAI 2022

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

May 19, 2022

U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner.

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

May 13, 2022

Several ACC 2022 late-breaking trials may have impacts on clinical practice for interventional cardiology and structural heart. One trial compared FFR vs. IVUS guided PCI for intermediate coronary lesions. Photos by Dave Fornell

Key interventional cardiology takeaways from ACC.22

Several late-breaking clinical trials at ACC.22 will likely impact clinical practice. Below are summaries of a few key trials and their takeaways for interventional cardiology and structural heart interventions.

April 11, 2022

What clinicians need to know about PCI, other revascularization techniques among women

The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization.

February 4, 2022

CMS finalizes 2022 Medicare Physician Fee Schedule—payments to cardiologists take a hit

Also, penalties for failing to comply with the Appropriate Use Criteria program have been delayed yet again.

November 3, 2021

Society for Cardiovascular Angiography Interventions (SCAI)

New-look TAVR valve shows early promise in patients with severe AS

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology

Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine